SELLAS Life Sciences (SLS) Divestments (2015 - 2016)
SELLAS Life Sciences (SLS) reported Divestments of -$1.0 million for Q1 2016, down 110.0% year-over-year from $10.5 million in Q2 2015, and down 109.31% quarter-over-quarter from $11.3 million in Q4 2015.
SELLAS Life Sciences (SLS) Divestments (2015 - 2016) Analysis & Trends
SELLAS Life Sciences (SLS) has 2 years of Divestments data on file, last reported at -$1.0 million in Q1 2016.
- Divestments for Q1 2016 came in at -$1.0 million, down 110.0% year-over-year; the trailing twelve-month figure through Dec 2016 was -$1.0 million (down 109.77% YoY), and the FY2016 annual result was -$1.0 million, down 109.77% from the prior year.
- Divestments eased to -$1.0 million in Q1 2016 per SLS's latest filing, from $11.3 million in the prior quarter.
- Over five years, Divestments peaked at $11.3 million in Q4 2015 and troughed at -$1.0 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -1.05 Mn |
| Dec 31, 2015 | 11.28 Mn |
| Jun 30, 2015 | -34,000.00 |
| Mar 31, 2015 | -500,000.00 |